Cargando…
A comparison of the effectiveness of cyclophosphamide, leflunomide, corticosteroids, or conservative management alone in patients with IgA nephropathy: a retrospective observational study
To compare the long-term efficacy of corticosteroids (P) alone or in combination with cyclophosphamide (CTX), leflunomide (LEF), or Angiotensin-convertase inhibitors or angiotensin II receptor blockers (ACEI/ARB) in treatment for IgA nephropathy (IgAN), 311 patients with IgAN were identified. Therap...
Autores principales: | Chen, Shasha, Yin, Qing, Ren, Song, Zhong, Xiang, Wang, Wei, Li, Guisen, Wang, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135814/ https://www.ncbi.nlm.nih.gov/pubmed/30209279 http://dx.doi.org/10.1038/s41598-018-31727-5 |
Ejemplares similares
-
Comparison of combined leflunomide and low-dose corticosteroid therapy with full-dose corticosteroid monotherapy for progressive IgA nephropathy
por: Min, Lulin, et al.
Publicado: (2017) -
Clinical efficacy and safety of full-dose versus half-dose corticosteroids plus leflunomide for IgA nephropathy
por: Li, Yebei, et al.
Publicado: (2021) -
Efficacy and safety of leflunomide combined with corticosteroids for the treatment of IgA nephropathy: a Meta-analysis of randomized controlled trials
por: Lv, Guangxin, et al.
Publicado: (2022) -
Oral glucocorticoids with intravenous cyclophosphamide or oral glucocorticoids alone in the treatment of IgA nephropathy present with nephrotic syndrome and mesangioproliferative glomerulonephritis
por: Du, Wen, et al.
Publicado: (2023) -
Leflunomide therapy for IgA vasculitis with nephritis in children
por: Hou, Ling, et al.
Publicado: (2021)